BridgeBio Pharma, Inc. (BBIO)
67.37
-0.24
(-0.35%)
USD |
NASDAQ |
Jun 08, 16:00
67.37
0.00 (0.00%)
After-Hours: 19:29
BridgeBio Pharma Shareholders Equity (Quarterly) : -2.278B for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Pfizer Inc. | 90.10B |
| Alnylam Pharmaceuticals, Inc. | 1.075B |
| Ionis Pharmaceuticals, Inc. | 491.41M |
| BioMarin Pharmaceutical, Inc. | 6.212B |
| Cytokinetics, Inc. | -826.57M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.371B |
| Total Liabilities (Quarterly) | 3.640B |
| Debt to Equity Ratio | -1.486 |
| Current Ratio | 1.520 |
| Net Debt Paydown Yield | -1.62% |